The experimental tobacco marketplace: Narrative influence on electronic cigarette substitution.
Journal
Experimental and clinical psychopharmacology
ISSN: 1936-2293
Titre abrégé: Exp Clin Psychopharmacol
Pays: United States
ID NLM: 9419066
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
pubmed:
6
11
2018
medline:
16
5
2019
entrez:
6
11
2018
Statut:
ppublish
Résumé
Despite promising decreases in overall smoking rates, a significant proportion of the population continues to engage in this costly behavior. Substituting e-cigarettes for conventional cigarettes is an increasingly popular harm-reduction strategy. Narratives may be one method of increasing the substitutability of e-cigarettes. Participants (N = 160) were assigned to 1 of 4 narratives that described a close friend becoming ill. In the positive narrative, participants read about a friend that became ill but learned it was only the flu. In the negative narrative, the friend became ill from smoking cigarettes; in the negative
Identifiants
pubmed: 30394764
pii: 2018-55627-001
doi: 10.1037/pha0000233
pmc: PMC6445377
mid: NIHMS984382
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115-124Subventions
Organisme : NIDA NIH HHS
ID : R01 DA034755
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA157345
Pays : United States
Organisme : Virginia Tech Carilion Research Institute
Organisme : National Institutes of Health
Références
Nicotine Tob Res. 2012 Jan;14(1):75-8
pubmed: 22025545
Patient Educ Couns. 2010 Dec;81 Suppl:S6-14
pubmed: 21071167
Nicotine Tob Res. 2016 May;18(5):524-30
pubmed: 26187389
Am J Prev Med. 2015 Mar;48(3):326-33
pubmed: 25498551
Nebr Symp Motiv. 2017;64:227-267
pubmed: 30351565
J Exp Anal Behav. 2011 Nov;96(3):427-39
pubmed: 22084499
Exp Clin Psychopharmacol. 2014 Jun;22(3):222-8
pubmed: 24708144
Nicotine Tob Res. 2018 Sep 4;20(10):1278-1282
pubmed: 29065197
Science. 2011 Dec 2;334(6060):1269-72
pubmed: 22144624
Perspect Behav Sci. 2018 Dec 12;42(1):163-180
pubmed: 31976427
Nicotine Tob Res. 2006 Jun;8(3):435-46
pubmed: 16801301
Tob Control. 2018 Jan;27(1):18-25
pubmed: 28970328
Psychopharmacology (Berl). 1999 Nov;147(2):210-6
pubmed: 10591889
Drug Alcohol Depend. 2001 Mar 1;62(1):31-9
pubmed: 11173165
Int J Drug Policy. 2015 Jun;26(6):595-600
pubmed: 25687714
Drug Alcohol Depend. 2008 May 1;95(1-2):169-72
pubmed: 18243583
Neuroimage. 2014 Nov 15;102 Pt 2:498-509
pubmed: 25128711
Behav Pharmacol. 2003 Mar;14(2):137-44
pubmed: 12658074
Health Commun. 2015;30(2):154-63
pubmed: 25470440
Harm Reduct J. 2009 Nov 03;6:29
pubmed: 19887003
Soc Sci Med. 2010 Jul;71(1):45-52
pubmed: 20417005
Health Psychol. 2008 Jan;27(1):110-5
pubmed: 18230021
Drug Alcohol Depend. 2017 Aug 1;177:14-22
pubmed: 28550711
Psychopharmacology (Berl). 2014 Dec;231(23):4517-26
pubmed: 24819731
Drug Alcohol Depend. 2017 Sep 1;178:551-555
pubmed: 28732318
Tob Regul Sci. 2017 Jul;3(3):266-279
pubmed: 31276024
PLoS One. 2018 Mar 14;13(3):e0193328
pubmed: 29538396
Nicotine Tob Res. 2016 Jul;18(7):1642-8
pubmed: 26470723
Prev Med. 2018 Dec;117:98-106
pubmed: 29702131
PLoS Med. 2016 May 10;13(5):e1002020
pubmed: 27163933
Harm Reduct J. 2013 Oct 04;10:19
pubmed: 24090432
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1233-40
pubmed: 26562061
PLoS One. 2015 Aug 17;10(8):e0135977
pubmed: 26280349
J Exp Anal Behav. 1993 Jul;60(1):141-158
pubmed: 16812696
PLoS One. 2015 Mar 30;10(3):e0122544
pubmed: 25822251
Psychopharmacology (Berl). 1999 Oct;146(4):447-54
pubmed: 10550495
Exp Clin Psychopharmacol. 2008 Jun;16(3):264-74
pubmed: 18540786
J Exp Anal Behav. 1980 Sep;34(2):219-38
pubmed: 16812188
Prev Chronic Dis. 2016 Mar 24;13:E42
pubmed: 27010845
Am J Public Health. 2015 Oct;105(10):2117-23
pubmed: 25905845
Soc Sci Med. 2008 Dec;67(12):2079-88
pubmed: 18951673
Exp Clin Psychopharmacol. 2015 Dec;23(6):504-12
pubmed: 26280591